PHARMACEUTICAL COMPOSITIONS COMPRISING AZD9291
The present invention relates to pharmaceutical compositions suitable for oral administration, and more particularly to pharmaceutical compositions, including pharmaceutical tablet compositions, containing N-(2-{2-dimethylaminoethyl-methylamino}- 4-methoxy-5-{[4-(1-methylindol-3-yl)pyrimidin-2-yl]am...
Saved in:
Main Authors | , , |
---|---|
Format | Patent |
Language | English |
Published |
25.02.2021
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present invention relates to pharmaceutical compositions suitable for oral administration, and more particularly to pharmaceutical compositions, including pharmaceutical tablet compositions, containing N-(2-{2-dimethylaminoethyl-methylamino}- 4-methoxy-5-{[4-(1-methylindol-3-yl)pyrimidin-2-yl]amino}phenyl) prop-2-enamide ("AZD9291") or a pharmaceutically acceptable salt thereof, wherein such compositions comprise a certain amount of microcrystalline cellulose and at least one other pharmaceutical diluent. |
---|---|
Bibliography: | Application Number: MY2016PI702433 |